All marketing authorization holders of medicine are hereby informed that NMRA decided to re-register multivitamin products which were registered as medicines under the CDDA Act can be continued under medicines based on the recommendation given by the 76th Medicines Evaluation Committee held on 28th March 2023.

(Date : 24 May 2023)

‍